Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Lamotrigine
Cat. No.:
OB0225LY-0452
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Lamotrigine is an antiepileptic reagent that is primarily used to modulate neuronal excitability.
Synonym:
LTG; BW430C; 84057-84-1; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; Lamictal; Lamictal Cd; Lamictal XR; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-
CAS No.:
84057-84-1
Compound CID:
3878
Formula:
C9H7Cl2N5
Formula Weight:
256.09
Specification
Relative Density:
1.572 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Lamotrigine can be used in studies of seizure mechanisms or play an important role in models of mood disorders.
Library Information
Targets:
Ion channels; G protein-coupled receptors (GPCRs)
Receptors:
5-HT receptor; Sodium channel
Pathways:
GPCR/G protein; Membrane transporter/Ion channel; Neuronal signaling; Autophagy
Plate Number:
AOCL-6
Plate Location:
g9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
18.33 mg/mL; 71.59 mM
Ethanol Max Solubility:
2.6 mg/mL; 10 mM
